"Nonhematologic Malignancy - Pipeline Review, H2 2013" Now Available at Fast Market Research
Global Markets Direct's, 'Nonhematologic Malignancy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Nonhematologic Malignancy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Nonhematologic Malignancy. Nonhematologic Malignancy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations...
View full press release